Dr. Mark D. Gonze, MD

Dr. Gonze practices at Podiatry Associates Ambulatory Surgical Centers - Cockeysville in Cockeysville, Maryland.

Dr. Gonze's NPI, 1538121983, was assigned on April 3, 2006. Dr. Gonze graduated from Penn State College of Medicine in 1991. Dr. Gonze holds Maryland license D54781.

Dr. Gonze's primary practice is Podiatry Associates Ambulatory Surgical Centers - Cockeysville, at 110 Old Padonia Road, Suite 301, Cockeysville, MD 21030. The practice phone is (410) 420-4116.

Dr. Gonze's primary practice is Podiatry Associates Ambulatory Surgical Centers - Cockeysville in Cockeysville, Maryland. Dr. Gonze is also affiliated with University of Maryland Medical Center. The medical group on file is Maryland Vascular Specialists. Dmand AI also links Dr. Gonze to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonze practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Gonze's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Gonze is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Gonze's licenses on file in 4 states: Maryland, Delaware, Louisiana and Pennsylvania.

Dmand AI lists amputation, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization, peripheral vascular disease and varicose veins among the conditions Dr. Gonze treats.

CMS data shows 2,719 Medicare services from Dr. Gonze across 39 procedure codes in 2024, for 692 Medicare patients. Medicare paid $663,092 for them.

CMS counts 692 Medicare patients who saw Dr. Gonze in 2024. The largest group is 65 to 74, with 297 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gonze's median patient age at 70, with 51% women.

In 2024, Dr. Gonze wrote 136 Medicare Part D claims for 71 patients. 71% of them were for generic drugs. CMS names the drug for 116 of them, across 4 drugs with 11 or more claims each, at $33,249 in total drug cost. In 2023, CMS named 65 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Gonze for performance year 2024, reported individually. Dr. Gonze accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of leg revascularization (restoring blood flow) by Dr. Gonze, more than 95% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Gonze in 2020. Dr. Gonze's most frequent co-authors are Richard A. Bafford, MD, MSPH, Charles C. Cummings, MD and Peter J. Mackrell, MD.

CMS Open Payments shows 70 general payments to Dr. Gonze from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Cardinal Health Inc paid the most, $790.

Dmand AI lists 2 awards for Dr. Gonze, most recently CMS Stage 1 EHR in 2013.

Dr. Gonze graduated from Penn State College of Medicine in 1991. Dr. Gonze is a member of ACS.

Dr. Gonze is in network with 21 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 13. Check the plan with the practice before a visit.